Objective: This randomized controlled trial tested the efficacy of motivational interviewing (MI) to reduce alcohol use among heavy drinking men who have sex with men (MSM) who are engaged in HIV care but not currently receiving addictions treatment. Method: One hundred eighty MSM living with HIV-recruited regardless of interest in changing drinking-were randomly assigned to MI or an assessment-only treatment as usual (TAU) control. MI comprised one in-person session followed by two brief phone calls and in-person booster sessions at 3 and 6 months. The Timeline Follow-Back Interview assessed past 30-day alcohol use and sexual behavior at 3, 6, and 12 months postbaseline, and serum samples and medical records assessed viral load, CD4 cell count, and liver function. Results: At 6 and 12 months, MI compared to TAU resulted in significantly fewer drinks per week (6 months: b ϭ Ϫ8.72, 95% confidence interval (CI) [Ϫ12.69, Ϫ4.76]; 12 months: b ϭ Ϫ5.98, 95% CI [Ϫ9.77, Ϫ2.19]) and lower number of heavy drinking days (6 months: incidence rate ratio ϭ 0.55, 95% CI [0.38, 0.79]; 12 months: incidence rate ratio ϭ 0.50, 95% CI [0.33, 0.78]). Effects on viral load, CD4 cell count, and liver function were nonsignificant. Among those reporting condomless sex with nonsteady partners at baseline, MI resulted in significantly lower rates of this behavior at 3 and 12 months compared to TAU. Conclusions: In MSM living with HIV, MI shows substantial promise for reducing heavy drinking and for reducing condomless sex among those at risk.
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Supplemental materials: http://dx.doi.org/10.1037/ccp0000322.supp Among people living with HIV (PLWH) rates of heavy, binge, or hazardous alcohol drinking range from 14% to 34%, depending on the sample studied and the definitions used (Centers for Disease Control and Prevention [CDC], 2016; Crane et al., 2017; Kahler et al., 2017) . About 19% of PLWH engaged in HIV care meet criteria for an alcohol use disorder (Hartzler et al., 2017) . These high rates of heavy drinking and alcohol use disorder are of great concern, given that greater alcohol use among PLWH is associated with numerous negative outcomes including lower antiretroviral therapy (ART) adherence (Barai et al., 2017; Hendershot, Stoner, Pantalone, & Simoni, 2009; Kahler et al., 2017) , poorer virologic control and lower CD4 counts (Barai et al., 2017; Deiss et al., 2016; Kahler et al., 2017) , increased risk of liver disease (Chaudhry, Sulkowski, Chander, & Moore, 2009; Fuster et al., 2013; Tsui et al., 2013) , greater HIV disease severity (Marshall et al., 2017) , and increased risk of all-cause mortality (Canan et al., 2017; DeLorenze, Weisner, Tsai, Satre, & Quesenberry, 2011) . Indeed, the relative risk of mortality associated with heavy drinking appears to be especially high in PLWH compared to those without HIV (Justice et al., 2016) . Research also indicates that heavy drinkers are less likely to be retained in HIV care than moderate or nondrinkers (Giordano et al., 2005; Monroe et al., 2016) , and greater alcohol and substance use may interfere with interventions to improve consistent engagement in care (Gardner et al., 2016) . The many deleterious effects of heavy drinking on HIV care outcomes underscore the need to develop and evaluate interventions to reduce heavy drinking in PLWH.
Men, and in particular men who have sex with men (MSM), have the highest rates of heavy drinking and alcohol use disorders among PLWH (Crane et al., 2017; Hartzler et al., 2017) . MSM represent almost half of PLWH currently receiving HIV care in the United States (CDC, 2016) , and rates of new infections continue to rise among this population (CDC, 2013) . Alcohol use may contribute to a higher HIV transmission risk and higher rates of sexually transmitted infections among MSM, given that heavy drinking in HIV-infected MSM has been associated with increased rates of condomless anal sex with serodiscordant partners (Bruce, Kahana, Harper, Fernández, & ATN, 2013; Kahler et al., 2015; Vosburgh, Mansergh, Sullivan, & Purcell, 2012) . Therefore, interventions to reduce heavy drinking in MSM living with HIV are a particularly important public health priority.
Interventions to Reduce Drinking in PLWH
A recent meta-analysis identified 21 randomized controlled trials published prior to 2017 that tested behavioral interventions to reduce drinking in PLWH (Scott-Sheldon, Carey, Johnson, Carey, & the MASH Team, 2017) . Overall, effect sizes for these interventions on drinking outcomes were found to be small but significant for reduced quantity of alcohol consumed (d ϭ 0.11) and frequency of heavy drinking (d ϭ 0.24). Only four trials tested an intervention that had an explicit primary focus on alcohol reduction with the remaining trials addressing alcohol use as part of combined interventions that also targeted ART adherence or sexual risk reduction as coprimary outcomes. There was evidence that interventions focused primarily on alcohol had stronger effects on reducing the frequency of drinking (d ϭ 0.56) compared to combined interventions (d ϭ Ϫ0.06). Of the 11 studies reporting on condom use as an outcome, the effect of intervention was significant and small (d ϭ 0.24) as was the case for the seven studies reporting on viral load as an outcome (d ϭ 0.14). Only two trials included in the meta-analysis focused on MSM, and neither intervention had a primary focus on alcohol reduction (Sikkema et al., 2011; Velasquez et al., 2009) . Therefore, more research is needed to establish the efficacy of alcohol-focused interventions in PLWH, especially among MSM.
Motivational interviewing (MI; Miller & Rollnick, 2012 )-a directive, patient-centered approach to motivating behavior change-is among the most well-established approaches to reducing heavy alcohol use (Burke, Arkowitz, & Menchola, 2003; Sayegh, Huey, Zara, & Jhaveri, 2017) . MI is especially appealing for use in HIV care settings because of its relatively brief duration compared to other evidence-based approaches, such as cognitivebehavioral therapy, and has shown promise in HIV care settings for increasing ART adherence and reducing sexual risk behavior (Dillard, Zuniga, & Holstad, 2017) . Alcohol interventions based in MI have been successfully tested in MSM both with and without HIV (Wray et al., 2016) , although no study has tested MI focused primarily on reducing alcohol use in MSM living with HIV.
In a sample of heavy-drinking MSM living with HIV, Velasquez and colleagues (2009) compared four sessions of individual MI plus four peer-led group sessions focused on both alcohol use and sexual risk behaviors to a resource referral control condition. The intervention resulted in significant reductions in drinking compared to the control group; however, the intervention effects dissipated over time, and drinking outcomes between conditions were very similar by the 12-month follow-up. In a sample of both male and female heavy drinkers living with HIV, Hasin and colleagues (2013) compared three intervention conditions with a primary alcohol focus over a 2-month period: (a) three sessions of brief advice versus (b) three sessions of MI (25, 15, and 15 min duration, respectively) versus (c) three sessions of MI plus a daily interactive voice response assessment. The MI conditions led to greater reductions in drinks per drinking day compared to brief advice, with MI plus interactive voice response showing the most robust effects (effect size d ϭ .44). However, condition differences became nonsignificant during the posttreatment follow-up (3 to 12 months after baseline). Specific analyses of MI effects for MSM participants were not reported. Finally, Wandera and colleagues (2017) tested a single 20 -30-min MI session focused on alcohol reduction in a sample of men and women living with HIV in Uganda. Results indicated a significant effect of MI versus an HIV education control condition on reduction in alcohol consumption at 6 months postintervention in women but not in men. This limited body of empirical research necessitates further study of whether This document is copyrighted by the American Psychological Association or one of its allied publishers.
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MI can produce robust and lasting reductions on alcohol use in MSM living with HIV.
Study Aims
The purpose of the present study-entitled Project ReACH (Reducing Alcohol-related Comorbidities in HIV treatment)-was to test the efficacy of MI to reduce heavy drinking in MSM engaged in HIV care compared to a treatment as usual (TAU) control condition, which involved only research assessments and usual HIV care in a community health center that also offers behavioral health services. We chose TAU as the comparison condition so we could determine the additive value of delivering MI on the same schedule as the usual HIV care appointments (typically 2-3 per year) that patients fully engaged with care receive. The Project ReACH intervention comprised an initial 60-min, in-person MI session with personalized feedback followed by up to two brief phone sessions and in-person booster sessions of 10 -20 min each at the 3-and 6-month follow-up visits. The intervention was novel in that it included in-depth personalized and normative feedback that was specific to PLWH and to MSM. Booster sessions were intended to reinforce and build upon successful behavior change and to encourage further consideration of change in those whose drinking remained heavy.
We hypothesized that MI, compared to TAU, would result in significantly greater reductions in alcohol use at follow-ups occurring 3 months, 6 months (end of active intervention period), and 12 months (6 months after the intervention concluded) after the baseline assessment. As a secondary aim, we tested whether MI compared to TAU would result in higher rates of HIV viral suppression, higher CD4 cell counts, improved liver function, and reduced rates of condomless sex with nonsteady partners. These other outcomes were secondary, because participants were not selected for elevations on these variables and, therefore, might have limited room to improve these outcomes even in the presence of substantial reductions in drinking.
Method

Study Design
We utilized a randomized controlled trial design, with outcome assessors blinded to study condition, to test the efficacy of MI with personalized feedback versus an assessment-only TAU control condition. Outcomes were assessed at 3, 6, and 12 months after the baseline assessment. The in-person intervention sessions occurred immediately following baseline assessment and the 3-and 6-month follow-up assessments. The study was approved by the Institutional Review Boards at Fenway Health and Brown University.
Sample size and power. Based on meta-analysis of MI effects on alcohol use (Burke et al., 2003) , we set desired sample size to detect a small to medium effect of MI of Cohen's d ϭ 0.35. We assumed three follow-ups (3, 6, and 12 months) with moderate correlations between assessments (r ϭ .60), which resulted in a necessary sample size of 190 (Rochon, 1998) . To allow loss to follow-up of 15%, we attempted to recruit an initial sample of 224. Recruitment fell short of this desired total, due primarily to the fact that we had approached most of the potentially eligible participants at the clinic by the end of the project. However, follow-up response rates were higher than anticipated, with loss to follow-up of only 10.6%. Overall, our recruited sample size of 180 provided us with power of .80 to detect an effect size d of 0.38.
Participants
Participants were 180 heavy-drinking MSM living with HIV recruited from a single urban community health center in in Boston, MA. This center cares for more than 2,000 MSM living with HIV. Men were either invited by staff to participate in the study during routine appointments with their HIV care provider or called into the study in response to flyers posted in the clinic rooms. To be eligible, participants had to (a) be at least 18 years old; (b) self-reported heavy drinking by National Institute on Alcohol Abuse and Alcoholism (NIAAA, 2010) criteria, namely drinking Ն14 drinks per week or drinking Ն5 drinks on a single occasion at least once in a typical month; (c) be diagnosed with HIV; and (d) report engaging in sex (oral or anal) with a male partner in the last 12 months or self-identify as gay/bisexual. Participants using ART had to have been stabilized on their current regimen for at least three months prior to enrollment. Participants were ineligible if they (a) reported current intravenous drug use, (b) were psychotic, suicidal, or manic at the baseline assessment, or (c) had been or were being treated for an HIV-related opportunistic infection in the past three months. Because we were interested in the effect of MI relative to HIV TAU, we excluded participants currently receiving treatment for an alcohol or drug problem because TAU was not intended to involve ongoing substance use treatment. See Table 1 for sample demographic characteristics.
Study Procedure
Participants were recruited from December 2011 through March 2015, and follow-up visits were conducted from March 2012 through May 2016. Recruitment materials were broadly targeted toward MSM living with HIV who drink alcohol and clearly stated that participants did not have to be interested in changing their alcohol use. Potential participants first completed a brief eligibility screener with study staff either in-person or by phone. Those who appeared eligible based on their responses were scheduled for an in-person baseline visit. Participants were asked to abstain from alcohol for 24 hr prior to this assessment, which was confirmed by alcohol breath analysis upon arrival. At the baseline visit, participants provided written informed consent, which informed participants that they would be randomized either to receive counseling around alcohol use or to complete only assessments with the option of receiving counseling after the final follow-up assessment. Potential participants then completed confirmatory screening for eligibility and the remainder of the baseline interview. At the conclusion of the baseline interview, the research assessor sent participant information to the project coordinator, who then randomized eligible participants using a computerized urn randomization program (Stout, Wirtz, Carbonari, & Del Boca, 1994) to ensure balance across study conditions on key variables: viral load, engagement in condomless sex with a seronegative or unknown partner in the past 3 months, current receipt of ART, and the number of alcoholic drinks consumed per week. The assessor also This document is copyrighted by the American Psychological Association or one of its allied publishers.
entered select baseline data into a computer program to generate a personalized feedback report for all participants. This report was printed and placed in a folder. The counselor only opened the folder containing the report if the participant was assigned to MI; participants randomized to TAU did not receive the report. (Note that the report was created by study staff who were blinded to randomization assignment, and this step aided in maintaining the blind.) After randomization, participants assigned to MI received the intervention immediately. Those assigned to TAU met briefly with a counselor who explained that they were not randomized to receive counseling, and that their participation for the day was complete. This procedure helped to retain the blinding to condition for the assessors (i.e., an assessor always passed off a participant to a counselor, regardless of randomization assignment). All participants were asked to come to the clinic for in-person follow-up visits at 3, 6, and 12 months after baseline. Participants were compensated $100 for completing the baseline interview and $40, $50, and $60 for completing the 3-, 6-, and 12-month follow-ups, respectively.
A total of 591 individuals were screened at the clinic or by phone. Figure 1 shows the Consolidated Standards of Reporting Trials (CONSORT) flow diagram of those participants through study milestones (Moher et al., 2010) . Ninety-one participants were randomized to TAU and 89 were randomized to MI. At the 3-month assessment the combined retention rate was 93% (TAU ϭ 97%, MI ϭ 89%), at the 6-month visit retention was 91% (TAU ϭ 95%, MI ϭ 88%), and at the 12-month visit retention was 89% (TAU ϭ 90%, MI ϭ 89%).
Measures
Demographic variables were collected at the baseline assessment. Current alcohol and substance use disorders, major depressive disorder, mania, and psychotic symptoms were assessed using the SCID-NP (Structured Clinical Interview for DSM-IV-TR for Axis I Disorders, Non-patient edition). (First, Spitzer, Gibbon, & Williams, 2007) . At baseline and each follow-up visit, study staff extracted clinical lab results from the medical record or ordered tests, if the required labs had not been completed in the past month. The secondary outcomes of interest from the clinical labs included plasma HIV RNA (dichotomized as detectable vs. undetectable, based on a lower limit of detection of 75 copies/mL), CD4 T-cell count (cells/l), and score on the liver fibrosis-4 index (FIB-4; Sterling et al., 2006; Vallet-Pichard et al., 2007) .
The Timeline Followback (TLFB) interview (Sobell et al., 1980) was used to assess alcohol and drug use as well as sexual behavior. The TLFB interview is a structured interview which uses Note. TAU ϭ treatment as usual; MI ϭ motivational interviewing; ART ϭ antiretroviral therapy. a Participants can select more than one race so the total across the categories is greater than the sample size.
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a calendar to cue a participant's memory and enhance accurate recall of behaviors. It has been shown to be a reliable and valid method of assessing alcohol and drug use (Maisto, Sobell, Cooper, & Sobell, 1979; Sobell et al., 1980) as well as sexual behavior (Carey, Carey, Maisto, Gordon, & Weinhardt, 2001; Weinhardt et al., 1998) . This interview assessed each occasion of sexual activity over the past 30 days, with detailed information on the type of partner (primary, casual, or anonymous); the HIV status of partner (positive, negative, or unknown); the type of sexual activity (oral, anal, vaginal; insertive or receptive); condom use (condom used or not used during a sexual behavior); and whether the participant was under the influence of alcohol or drugs at the time of sex. The TLFB provided the primary drinking outcome measures, which were (a) average number of drinks consumed per week and (b) number of heavy drinking days (Ն5 drinks in a given day) in the past 30 days. The TLFB also provided the secondary behavioral outcomes: the number of days participants had engaged in condomless anal or vaginal intercourse with a nonsteady (i.e., casual or anonymous) partner and the number of days having sex while under the influence of alcohol or drugs.
Behavioral Intervention
The MI condition consisted of one in-person counseling session at baseline, lasting up to 60 min, and two additional in-person counseling sessions at the 3-and 6-month follow-up visits, each lasting up to 20 min. Counselors also conducted up to two brief phone calls after the baseline session to check-in on participants' progress toward goals, and to discuss any reactions to the counseling session. The MI incorporated each of the elements of the FRAMES approach, described by Miller and Rollnick (Miller & Rollnick, 2002) : feedback and discussion on the potential effects This document is copyrighted by the American Psychological Association or one of its allied publishers.
of drinking on virologic and immune functioning, ART adherence, liver functioning, cognitive functioning, sexual risk behavior, and other substance use; an emphasis on personal responsibility for deciding to change their behavior; advice to avoid or reduce drinking; a menu of options for carrying out a change strategy for participants indicating a willingness to do so; the use of empathy by the clinician; and the encouragement of self-efficacy for successful change. The intervention drew heavily from techniques of MI, which are intended to minimize resistance and support selfefficacy for change. Counselors provided feedback and advice in a nonconfrontational manner that avoided labeling and consistently stressed the participant's personal responsibility for change. Baseline session. In the initial session, counselors asked participants to describe their current drinking patterns, the positive and potential negative aspects of their drinking, how their drinking had changed since becoming infected with HIV, and what connection they saw between drinking and their HIV treatment. The counselor reflected and amplified participant statements supporting change in drinking. Together, the counselor and participant reviewed the personalized feedback report. The report compared participants' self-reported drinking to normative data on drinking for MSM living in urban settings and provided information on participants' HIV viral load, CD4 count, ART adherence, liver function, cognitive function, sexual risk behavior, and other substance use. Counselors used this feedback to develop discrepancies between a goal of living successfully with HIV and continued heavy drinking by discussing how any identified concerns might relate to their current drinking. Discussions focused primarily on how alcohol use might impact health behaviors (i.e., sexual behavior, ART adherence, and co-occurring substance use), but also included brief discussion of motivation for and problem solving about barriers to changing those health behaviors, as appropriate. Counselors provided the NIAAA recommendations for low-risk drinking (i.e., no more than 14 drinks per week for men and never drinking more than 4 drinks a day; NIAAA, 2005) but also stated there is no known "safe" level of drinking for PLWH, especially for individuals with hepatitis coinfection. Counselors asked participants if they wanted to make a change plan around drinking, providing a menu of alternative goals to participants who had difficulty formulating a goal. The session content then focused on increasing participants' self-efficacy for changing their drinking and problem-solving regarding how to meet their collaboratively determined drinking goals. Participants were provided a self-help pamphlet, "Tips for Cutting Down on Drinking" (NIAAA, 2010), which provides specific strategies for limiting drinking. Participants indicating an intention to stop drinking were provided referrals to Alcoholics/Narcotics Anonymous and to local addictions treatment programs, if interested.
Phone sessions. Counselors called participants approximately two weeks after the initial session to conduct a brief (ϳ5-min) check-in to discuss reactions to the session, to follow up on goal setting from the session, and to review behavior change progress. They also offered an optional call to participants at eight weeks postbaseline.
Booster sessions. In-person booster sessions at three and six months postbaseline were intended to reinforce changes in drinking since the last assessment and, for those who had not changed their drinking, to consider further the potential benefits of change. Counselors provided feedback on the participant's drinking over the prior 3 months and followed-up on change plans made previously. Counselors provided feedback on any updated clinical lab results, such as liver function tests. The second booster session, at 6 months postbaseline, included a brief discussion of ways to maintain changes in drinking over the longer term, as this was the final in-person component of the intervention.
Counselors
Counseling sessions were provided by three master's-level treatment project staff (two cisgender men and one cisgender woman), all of whom had previous experience working in clinical or research contexts with MSM populations and PLWH. Detailed treatment manuals were used to ensure standardization of treatment delivery. Counselors received approximately 20 hr of training in the study protocol and MI, including readings and role-playing exercises. All intervention sessions were audio recorded, and counselors attended weekly clinical supervision where they discussed current cases and received feedback based on audiotape review of sessions.
Intervention Integrity
All 89 baseline MI sessions and 74 out of 76 in-person MI booster sessions at 3 months were audio-recorded and coded to evaluate MI integrity and fidelity using the Motivational Interviewing Skill Code Version 2.5 (MISC; Houck, Moyers, Miller, Glynn, & Hallgren, 2010) . Each session was parsed and coded by independent raters. Four independent raters were trained and then coded the 163 recordings, with double coding conducted on 18.4% (N ϭ 30) of sessions to determine interrater reliability using intraclass correlation coefficients. With the exception of Collaboration, reliabilities for MISC global ratings were all in the "good" or "excellent" range according to criteria established by Cicchetti (Cicchetti, 1994): empathy ϭ .78, support autonomy ϭ .66, collaboration ϭ .49, acceptance ϭ .83, evocation ϭ .70, direction ϭ .81. Counselors showed high levels of fidelity to MI practices. MISC global skills ratings ranged from 3.72 (baseline collaboration) to 4.28 (3-month acceptance) on a 5-point scale ranging from 1 (low) to 5 (high). Eighty of 89 (89.9%) baseline sessions and 71 of 74 (95.9%) 3-month booster sessions had all therapist global ratings at 3 or higher. The minimum score for any global rating was 2.
Data Analysis Plan
Study enrollment and follow-up data were summarized using the recommended CONSORT approach for randomized controlled trials (Moher et al., 2010) . The study population was characterized using baseline characteristics stratified by intervention condition. Following CONSORT recommendations, we did not test for significant baseline differences but, instead, examined whether there were substantial differences between conditions on key prognostic variables that might impact outcomes.
We compared the primary outcomes related to reductions in self-reported alcohol use over the study period at 3, 6, and 12 months by study arm, including: (a) average drinks per week at each follow-up; and (b) total number of heavy drinking days per month. The secondary outcomes included detectable viral load, This document is copyrighted by the American Psychological Association or one of its allied publishers.
CD4 count, FIB-4, days of having condomless sex with nonsteady partners, and days having sex while under the influence of alcohol or drugs. These primary and secondary outcomes were summarized by intervention arms and study visits, using median/interquartile range for continuous outcomes and percent for dichotomous outcomes. Using the summary statistics, the temporal changes of the study outcomes were examined for each arm. The effect size of MI versus TAU at each study visit was reported using Cohen's d for continuous outcomes and h for dichotomous outcomes. We then conducted a longitudinal regression analysis to compare the effect of MI versus TAU on the primary drinking outcomes over the 12-month study period. The regression analysis was based on the following generalized linear models (GLMs; McCullagh & Nelder, 1989) :
in which E(Y) was the expected value of study outcome; the intercept ␣ was the average baseline outcome (which we assume was the same for both arms due to randomization); T j 's were dummy variables created for the three follow-up visits so that ␤ 1 , . . . , ␤ 3 captured the longitudinal changes (differences from the baseline) of the outcomes for participants randomized to the TAU control condition; and R was a dummy variable for study arm (R ϭ 1 if MI; R ϭ 0 if TAU) so that ␤ 4 , . . . , ␤ 6 coded the effect of MI compared with TAU at each of the study follow-ups. An omnibus Wald test was also conducted to test jointly that ␤ 4 ϭ ␤ 5 ϭ ␤ 6 ϭ 0 (i.e., to test the null H 0 : no differences between MI and TAU at any follow-up visit; vs. the alternative H a : differences exist between MI and TAU). The model was adjusted for the following baseline covariates (T 0 ) that were used in the urn randomization: any condomless anal or vaginal intercourse with an HIV-negative or unknown partner in the past 3 months at baseline, a detectable viral load at baseline (Ͼ75 copies/mL), and the average standard drinks per week measured 30 days prior to baseline, which was divided into four levels: Յ10 drinks, 11-17 drinks, 18 -28 drinks, Ͼ28 drinks. Given that almost all participants were on ART at baseline (93.9%), this factor was not included as a covariate in the analyses.
Depending on the distributional properties of the outcomes, we chose the link function (h{.}) as follows: For average drinks per week, we used the identify link and fit a linear regression model; for number of heavy drinking days, we chose the log link function and fit negative binomial regression models, to account for the overdispersion from the Poisson distribution. Moreover, to account for the within-subject correlation due to repeated measures, all models were estimated by the method of generalized estimating equations (Liang & Zeger, 1986) , with a compound symmetry within-subject correlational structure employed as the working correlation matrix for obtaining robust sandwich standard errors. p Values of Ͻ0.05 were considered as statistically significant. We performed model goodness-of-fit diagnostics using the Quasilikelihood under the independence model criterion analysis. Data management was carried out using SPSS (Version 22) and SAS (9.4); all analyses were conducted using SAS.
Missing data. The analyses described above used only the available-case information. To examine potential impact of missing data on the analysis results, we used multiple imputation to impute the missing values at the baseline survey and during follow-up visits and repeated the regression analyses using the imputed data (Little & Rubin, 2002) . Details of the multiple imputation procedure and analysis results are provided as online supplementary materials. Results were highly consistent with those not using imputation and, therefore, are not detailed further here.
Results
The demographic and HIV-related clinical characteristics of the sample as a whole and within each condition are shown in Table  1 . Overall, conditions were well-balanced on these characteristics with only small difference on any given variable. All participants assigned to MI received the initial session with 66 (74.2%) receiving a 2-week call, and 34 (38.2%) receiving the optional 8-week call. Seventy-six participants (85.4%) received both in-person booster sessions, four (4.5%) received one of the two in-person booster sessions, and nine (10.1%) received no in-person booster sessions. Table 2 displays summaries of unadjusted study outcomes at baseline and follow-up. At the 6-month and 12-month follow-up, participants assigned to MI, compared to those in TAU, reported a significantly lower number of drinks consumed per week and fewer heavy drinking days over the prior 30 days. Effects sizes were in the small to medium range of d ϭ Ϫ.33 to Ϫ.50.
Summary of Study Outcomes at Baseline and Follow-Up
With the exception of CD4 cell count and having sex under the influence of alcohol or drugs, secondary outcomes reported in Table 2 showed no significant differences between TAU and MI at the baseline and follow-up visits. CD4 values showed no consistent pattern of change across conditions. The significantly lower CD4 counts seen at baseline in the MI condition compared to TAU-the only statistically significant baseline difference seenbecame less pronounced over the follow-up period.
Participants receiving MI, compared to those in TAU, reported significantly fewer days of sex under the influence at 3 months only. Because sexual risk outcomes showed the most indication of possible MI effects, we repeated those analyses, excluding those participants who did not exhibit the respective risk behavior at the baseline assessment. When we limited the analysis to participants who reported at least one day of condomless sex with a nonsteady partner at baseline (n ϭ 70), those receiving MI compared to those in TAU reported significantly fewer days of condomless sex at 3 months (d ϭ 0.61, p ϭ .006) and 12 months (d ϭ 0.37, p ϭ .039) but not at 6 months (d ϭ 0.42, p ϭ .12). Likewise, when we limited the analysis to participants who reported at least 1 day of sex under the influence at baseline (n ϭ 101), those receiving MI compared to those in TAU reported significantly fewer days of sex under the influence at 3 months (d ϭ 0.45, p ϭ .012) and 12 months (d ϭ 0.14, p ϭ .027) but not at 6 months (d ϭ 0.03, p ϭ .33). Table 3 displays the results of the GLM models for the primary outcomes of drinks per week and number of heavy drinking days This document is copyrighted by the American Psychological Association or one of its allied publishers.
Longitudinal Effects of Intervention Condition
at 3, 6, and 12 months. Consistent with hypotheses, the omnibus Wald tests indicated that there were significant differences between MI and TAU across these assessments for both drinks per week, 2 (3) ϭ 19.35, p ϭ .0002, and heavy drinking days ( 2 (3) ϭ 13.44; p ϭ .004). For drinks per week, the TAU condition showed a gradual reduction in consumption that became significant at the 12-month follow-up, representing about a 25% reduction in drinking. By contrast the reduction in drinking in MI was greater than 50% at both 6 and 12 months. Compared to TAU, those in MI reported significantly fewer drinks per week at both 6 (8.72 drinks less) and 12 months (5.98 drinks less) postbaseline.
Those in TAU reported gradual reductions in heavy drinking days over time that were significant at 12 months, representing a 27% lower number of heavy drinking days compared to baseline. Participants receiving MI showed steeper reductions in heavy drinking, of over 63% by 12 months. Compared to TAU, those in MI reported significantly fewer heavy drinking days at both 6 (45% lower count) and 12 months (50% lower count) postbaseline.
At 12 months, 49 out of 79 (62.0%) participants in MI continued to meet NIAAA criteria for heavy drinking compared to 64 of 82 (78.1%) in TAU, 2 (1, N ϭ 161), p ϭ .026.
Discussion
Results of this randomized controlled trial provide strong evidence that compared to TAU, a single-session MI with personalized HIV-and MSM-specific feedback, followed by brief phone calls and two booster sessions over a 6-month period, can result in substantial and sustained reductions in alcohol use among heavydrinking MSM engaged in HIV care who are not seeking alcohol treatment. The findings that (a) reductions in drinking in the intervention condition grew stronger from 3 to 6 months and (b) intervention effects were maintained from 6 to 12 months-when no interventions were delivered during that time period-were particularly notable. The change in drinking from 3 to 6 months may reflect the effect of the booster session that occurred at the .08 .41 3 months 1.8 (3.0), na ϭ 3 1.0 (2.2), na ϭ 10 Ϫ.28 .04 6 months 1.7 (3.1), na ϭ 5 1.6 (4.0), na ϭ 11 Ϫ.04 .20 12 months 1.9 (2.5), na ϭ 9 1.6 (3.4), na ϭ 10 Ϫ.09 .11
Note. na ϭ number of participants without available data on a given measure; TAU ϭ treatment as usual; MI ϭ motivational interviewing; FIB-4 as (Age (years) ϫ AST level (U/L))/(Platelet Count (10 9 /L) ϫ ͌ALT(U|L)). a Differences between study arms were summarized by Cohen's d (for continuous outcomes) or h (for binary outcomes).
b p values were calculated using student's t-test.
c Wilcoxon rank sum test. d Fisher's exact test.
3-month follow-up or may simply reflect the outcome of ongoing changes in drinking that were catalyzed by the initial counseling session. The effect of the intervention at the 12-month follow-up is especially important. Participants in TAU significantly reduced their drinking at 12 months relative to baseline. This reduction could reflect reactivity to repeated in-depth assessments of alcohol use and problems (Clifford & Davis, 2012) , which may cause participants to reflect on their drinking and serve as a mild form of intervention. Despite this apparent assessment reactivity in the TAU condition, the effect of MI was significant and sizable, about six fewer drinks consumed per week and about 50% fewer heavy drinking days compared to TAU. Second, prior studies using MI in PLWH have shown intervention effects on alcohol use that diminish over time, often becoming nonsignificant at the longer-term follow-up visits (e.g., Hasin et al., 2013; Parsons, Golub, Rosof, & Holder, 2007; Velasquez et al., 2009) . The current study provides evidence that the Project ReACH intervention can result in clinically meaningful sustained changes.
Previous studies that have failed to show long-term reductions in drinking via MI in PLWH have had more active control conditions than TAU (Hasin et al., 2013; Parsons et al., 2007) . In a study of heavy drinking women living with HIV, Chander and colleagues (2015) used an assessment only control and, similar to the current study, found brief intervention effects extending through 12-month follow-up. However, those effects were limited to only one alcohol outcome, the odds of having a drinking day. The intervention we tested was unique compared to motivational interventions in prior studies (Chander et al., 2015; Hasin et al., 2013) , as Project ReACH provided in-depth normative and personalized feedback on drinking, information regarding other aspects of health related to HIV, and extended conversations about drinking and personal goals. The level of depth of the current intervention may account, in part, for its relatively large and lasting effects; for example, in-depth motivational intervention has been shown to outperform brief advice in heavy drinking emergency department patients (Monti et al., 2016) . Two important open questions in this line of research are (a) whether booster sessions are needed to produce long-term changes in drinking and (b) whether the more in-depth motivational intervention employed in the current study would outperform a less intensive brief advice intervention that could be implemented without significant training and resources.
The current study was only the third to focus primarily on addressing alcohol use in HIV-infected MSM and only one of a small number of trials testing alcohol interventions in MSM with or without HIV (Wray et al., 2016) . It may be that the robust nature of the intervention effect found in the present study resulted, in part, from the fact that the intervention was specifically targeted to MSM, including MSM-specific normative feedback, and took d Negative-binomial model was fit for number of heavy drinking days. With the exception of the intercept, which is the baseline incidence rate, the model coefficients are incidence rate ratios. This document is copyrighted by the American Psychological Association or one of its allied publishers.
place in a community health center dedicated to serving the LG-BTQ community. The intervention tested in the current study could be readily adapted for other people living with HIV, and further trials of this approach in diverse samples of PLWH are warranted. At the same time, the fact that 62% of participants receiving MI continued to meet heavy drinking criteria at 12-month follow-up suggests that further research is needed to maximize intervention effects. MI, compared to TAU, did not show significant effects on secondary biomedical outcomes of viral load, CD4 cell count, and liver function. MI, compared to TAU, resulted in significantly less sex under the influence at 3 months but not 6 or 12 months, and the effect on condomless sex with a nonsteady partner was nonsignificant. The current sample was not selected based on risk for any of the secondary outcomes and, overall, secondary outcomes had little room for improvement relative to baseline. The vast majority of participants had undetectable viral loads at baseline, and most had CD4 cells counts and liver function tests in the normal range. We observed variability in the sexual behavior outcomes, and subsequent exploratory analyses limited to those who had engaged in a given sexual risk behavior at baseline did show significant effects of MI (compared to TAU) on reduced frequency of sex under the influence and condomless sex with a nonsteady partner at the 3-and 12-month follow-ups. A large multisite study could recruit patients with specific clinical profiles (e.g., detectable viral load, abnormal liver function, or high frequency of sexual risk behaviors) and examine with far more statistical power whether the effects of the intervention on self-reported alcohol use precipitate improvements in biomedical and behavioral outcomes.
Strengths and Limitations
The current study recruited a relatively large sample of MSM living with HIV and had strong retention of these participants of about 90% over a 12-month follow-up period. The counselors provided the manualized intervention with high fidelity to the principles of MI, and intervention effects were robust, including when multiple imputation approaches were applied to account for missing data. The Project ReACH intervention, although more in-depth than some other brief interventions tested in PLWH (Chander et al., 2015; Hasin et al., 2013 )-which have used as little as 40 -50 min of contact time-nonetheless required only about two hours of total contact time over the 6-month intervention period. Therefore, this approach could be readily disseminated, given availability of a suitably trained counselor.
The study was limited in its ability to test the effects of the intervention on secondary outcomes, as noted above. The sample recruited was engaged with care and virally well-controlled, and the majority of participants identified as non-Hispanic and White and may not generalize to MSM in other care settings. The comparison condition did not involve an active intervention, such as brief advice, and, therefore, the effects of MI shown must be interpreted as effects relative to assessment only. Finally, the study relied on self-reports of alcohol consumption. Although this has been standard practice in previously published clinical trials of alcohol interventions in PLWH, collection and analysis of biochemical markers of alcohol consumption, such as phosphatidylethanol, would be valuable in future studies and are being increasingly employed in studies of PLWH (Littlefield et al., 2017; Muyindike et al., 2017; Walther et al., 2015) .
Conclusions
Relatively brief motivationally focused alcohol intervention, compared to TAU, can result in substantial sustained reductions in alcohol use among heavy drinking MSM living with HIV over a 12-month period. Further research is needed to test the extent to which these reductions in drinking lead to important clinical outcomes, such as increased HIV viral suppression, reduced risk of liver disease, and reduced frequency of condomless sex with casual partners. Further research also should address the extent to which regular assessment of alcohol use can lead to reductions in drinking in PLWH, the level of intensity of intervention needed to produce maximal changes in drinking, and ways to implement alcohol interventions in a range of HIV care settings in a sustainable and cost-effective manner.
